Guru Ownership Trend
Guru Analysis for Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics, Inc. (VKTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.13 M.
Top institutional holders include Joel Greenblatt and Ray Dalio.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $13.44 M net outflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position. Conversely, Ray Dalio reduced exposure by 31.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Viking Therapeutics, Inc. (VKTX)
Major holders include Joel Greenblatt ($8.49 M), Ray Dalio ($2.32 M), Paul Tudor Jones ($2.3 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 414,968 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $13.44 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited VKTX. The total reported sell value was $15.25 M.
Yes, 1 managers opened new positions in VKTX, and 2 increased their existing holdings. The total reported buy value was $1.81 M.